4.7 Review

Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2021.646233

关键词

diabetes mellitus; complication; microvascular damage; mesenchymal stem cells; exosomes

资金

  1. east hospital affiliated to Tongji University introduced talent research startup fund [DFRC2019008]
  2. China Postdoctoral Science Foundation [2019M651587]

向作者/读者索取更多资源

Diabetes mellitus is a metabolic disease characterized by high blood sugar levels, often accompanied by various complications. Mesenchymal stem cell exosomes possess repair functions, low immunogenicity, and ease of storage and transportation, making them a potentially effective treatment for diabetes and its complications.
Diabetes mellitus (DM) is a metabolic disease, now prevalent worldwide, which is characterized by a relative or absolute lack of insulin secretion leading to chronically increased blood glucose levels. Diabetic patients are often accompanied by multiple macrovascular complications, such as coronary heart disease, hypertension, macrovascular arteriosclerosis, and microvascular complications. Microvascular complications include diabetic kidney injury, diabetic encephalopathy, and diabetic foot, which reduce the quality of life and survival status of patients. Mesenchymal stem cell exosomes (MSC-Exos) possess repair functions similar to MSCs, low immunogenicity, and ease of storage and transport. MSC-Exos have been proven to possess excellent repair effects in repairing various organ damages. This study reviews the application of MSC-Exos in the treatment of DM and its common complications. MSC-Exos may be used as an effective treatment for DM and its complications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据